Works matching IS 01676997 AND DT 2007 AND VI 25 AND IP 5

Results: 13

The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II study.

Published in:

Investigational New Drugs, 2007, v. 25, n. 5, p. 479

By:

Armando Santoro;
Lorenza Rimassa;
Roberto Doci;
Riccardo Rosati;
Vittorio Pedicini;
Giuseppe Gullo;
Monica Zuradelli;
Giovanni Abbadessa;
Emanuela Morenghi;
Ilaria Marcon;
Isabella Garassino

Publication type:

Article

In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression.

Published in:

Investigational New Drugs, 2007, v. 25, n. 5, p. 417

By:

Ulrike Eismann;
Olaf Oberschmidt;
Heike Pospisil;
Steve Hoffmann;
Hartmut Hanauske-Abel;
Doreen Ma;
Victor Chen;
Paolo Paoletti;
Clet Niyikiza

Publication type:

Article

Different cell cycle modulation following treatment of human ovarian carcinoma cells with a new platinum(IV) complex vs cisplatin.

Published in:

Investigational New Drugs, 2007, v. 25, n. 5, p. 435

By:

Viktor Horváth;
Karel Souček;
Lenka Švihálková-Šindlerová;
Jan Vondráček;
Olga Blanářová;
Jiřina Hofmanová;
Petr Sova;
Alois Kozubík

Publication type:

Article

Phase II study of Triapine® in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161).

Published in:

Investigational New Drugs, 2007, v. 25, n. 5, p. 471, doi. 10.1007/s10637-007-9044-9

By:

Jennifer Knox;
Sebastien Hotte;
Christian Kollmannsberger;
Eric Winquist;
Bryn Fisher;
Elizabeth Eisenhauer

Publication type:

Article

Modulation of tumor radiation response with G3139, a bcl-2 antisense oligonucleotide.

Published in:

Investigational New Drugs, 2007, v. 25, n. 5, p. 411

By:

Masashi Koto;
Uma Raju;
Luka Milas;
Kathryn Mason

Publication type:

Article

Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC).

Published in:

Investigational New Drugs, 2007, v. 25, n. 5, p. 445, doi. 10.1007/s10637-007-9050-y

By:

Charles Ryan;
Walter Stadler;
Bruce Roth;
Douglass Hutcheon;
Shauna Conry;
Thomas Puchalski;
Charles Morris;
Eric Small

Publication type:

Article

Dimethylamino-functionalised and N -heteroaryl-substituted titanocene anticancer drugs: synthesis and cytotoxicity studies.

Published in:

Investigational New Drugs, 2007, v. 25, n. 5, p. 425, doi. 10.1007/s10637-007-9061-8

By:

Thomas Hickey;
James Claffey;
Eoin Fitzpatrick;
Megan Hogan;
Clara Pampillón;
Matthias Tacke

Publication type:

Article

Docetaxelâifosfamide combination in patients with HER2 -non-overexpressing advanced breast cancer failing prior anthracyclines.

Published in:

Investigational New Drugs, 2007, v. 25, n. 5, p. 463

By:

Nicolas Tsavaris;
Nikolaos Malamos;
George Tsakonas;
Argyris Gassiamis;
Aristidis Polyzos;
Nicolas Mylonakis;
Athanasios Karabelis

Publication type:

Article

Silencing of endo-exonuclease expression sensitizes mouse B16F10 melanoma cells to DNA damaging agents.

Published in:

Investigational New Drugs, 2007, v. 25, n. 5, p. 399

By:

Slobodan Devic

Publication type:

Article

Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors.

Published in:

Investigational New Drugs, 2007, v. 25, n. 5, p. 487, doi. 10.1007/s10637-007-9059-2

By:

Darren Feldman;
G. Kondagunta;
Michelle Ginsberg;
Nicole Ishill;
Sujata Patil;
John Cestaro;
Eugenie Obbens;
Joel Sheinfeld;
George Bosl;
Robert Motzer

Publication type:

Article

Effects of dutasteride on the expression of genes related to androgen metabolism and related pathway in human prostate cancer cell lines.

Published in:

Investigational New Drugs, 2007, v. 25, n. 5, p. 491, doi. 10.1007/s10637-007-9070-7

By:

Michela Biancolella;
Alessandra Valentini;
Daniela Minella;
Lucia Vecchione;
Franca D’Amico;
Giovanni Chillemi;
Paolo Gravina;
Susana Bueno;
Gianluca Prosperini;
Alessandro Desideri;
Giorgio Federici;
Sergio Bernardini;
Giuseppe Novelli

Publication type:

Article

A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2Â weeks in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2007, v. 25, n. 5, p. 453, doi. 10.1007/s10637-007-9071-6

By:

Carmen Kahatt;
Sandrine Faivre;
Stephen Shibata;
Werner Hilgers;
FranÃ§ois Goldwasser;
FranÃ§ois Lokiec;
Eric Raymond;
Garry Weems;
Ajit Shah;
John MacDonald

Publication type:

Article

Amrubicin for non-small-cell lung cancer and small-cell lung cancer.

Published in:

Investigational New Drugs, 2007, v. 25, n. 5, p. 499, doi. 10.1007/s10637-007-9069-0

By:

Takayasu Kurata;
Isamu Okamoto;
Kenji Tamura;
Masahiro Fukuoka

Publication type:

Article